3M (MMM) Q3 2025 10-Q Quarterly Report
Filed: Oct 21, 2025Period ending Sep 30, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR 3M (MMM) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 21, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
3M Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue and YoY change not disclosed in provided text
- • Profitability or margin figures not mentioned
Risk Factors
- • New legal risk: $10.5-$12.5B PFAS class-action settlement approved March 2024 with payments 2024-2036, impacting cash flows and financial position
- • Updated operational risk: accelerating exit from PFAS manufacturing by end of 2025, with supply chain and substitute sourcing challenges affecting product portfolio
3M Q3 2025 Quarterly FinancialsXBRL
Revenue
$6.5B
▲ +3.5% YoY▲ +2.7% QoQ
Net Income
$834M
▼ -39.2% YoY▲ +15.4% QoQ
Operating Margin
22.2%
▲ +129bp YoY▲ +423bp QoQ
Net Margin
12.8%
▼ -900bp YoY▲ +140bp QoQ
ROE
18.0%
Total Assets
$37.6B
EPS (Diluted)
$1.55
▼ -37.5% YoY▲ +15.7% QoQ
Operating Cash Flow
$1.8B
▲ +198.3% YoY▲ +284.1% QoQ
Source: XBRL data from 3M Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other 3M Quarterly Reports
Get deeper insights on 3M
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.